Related Experiment Video
Updated: Jun 15, 2025
08:56
Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
2.9K
Harnessing Senescence for Antitumor Immunity to Advance Cancer Treatment
Radiation Research
|August 27, 2024
Summary
This study proposes a novel cancer treatment strategy by transiently inducing senescent cells to prime the immune system, followed by eliminating these cells with senolytics to unleash lasting antitumor immunity.
Area of Science:
- Oncology
- Immunology
- Gerontology
Background:
- Current cancer treatments face limitations and complexities.
- Senescent cells can promote tumor progression but also elicit antitumor immune responses when acutely induced.
- Apoptotic cells are immunologically silent, unlike senescent cells.
Purpose of the Study:
- To develop an unconventional conceptual framework for advancing cancer treatment.
- To integrate advances in energy delivery, senescence research, and immunomodulators.
- To propose a strategy leveraging senescent cells for enhanced immunotherapy.
Main Methods:
- Transiently inducing senescent cells in tumors using radiation.
- Eliminating senescent cells with senolytics to prevent accumulation and adverse effects.
- Utilizing immunomodulators to unleash long-lasting antitumor immunity.
Main Results:
- Acutely induced senescent cells can elicit a strong and lasting antitumor immune response.
- Eliminating senescent cells disrupts positive feedback accumulation, preventing tumor maladaptation.
- The proposed approach aims to unleash potent, long-lasting antitumor immunity.
Conclusions:
- This speculative approach requires rigorous preclinical research and development.
- Optimization of radiation and senolytic drug doses and schedules is crucial.
- The framework aims to advance cancer therapy by harnessing senescence and immunotherapy.
Related Concept Videos
02:15Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K